Biosimilars Market report segmented the market by product types, services & geography with in-depth analysis on revenue, trends, growth, share, size & forecast by 2022.

1. Biosimilars Market
Forecast – 2014 To 2022

2.  In-depth analysis of the market segments that will showcase the greatest growth
potential
 Information about the technological advancements influence the growth of the
global market
 Extensive analysis of the key players dominating the competitive landscape of this
market
 Browse the report : Biosimilars Market
Key Benefits Of The Report

3.  The biosimilars market offers many growth opportunities and driving factors as compared to
the restraining factors. It is stated by various research scientists that development of
biosimilars will drastically reduce the price of the pharmaceutical drugs.
 A large number of key companies such as Hospira, Inc., Teva Pharmaceutical, Amgen, and
others are in constant efforts to develop biosimilars and are rigorously increasing their research
& development expenses on clinical trials to introduce novel biosimilars, driving the market
growth.
 Amgen, Inc. has a strong research pipeline (phase III molecule) for the biosimilar products,
such as ABP 501, ABP 980, and ABP 215.
 The demand for biosimilars is also expected to increase due to the rise in the incidences of
the diseases such as cancer, cardiovascular diseases, and such others. For these diseases,
biosimilars have proven a promising option for the disease diagnosis and mitigation.
 Other factors such as rising number of off-patented drugs, positive result of many biosimilar
clinical trials and others drive the market growth to a great extent.
 However, a strict regulatory framework for the biosimilar manufacturers to develop these
products restr
Key Premium Industry Insights

4. Microeconomic
Indicators
Mesoeconomic
Indicators
Macroeconomic
Indicators
Data Collection
& Analysis
 The research methodology for Scalar Market Research’s Biosimilars market report
utilizes a combination of top-down and bottom-up research formats.
 Our primary focus on continuous market tracking, rigorous fact-checking, data-
triangulation, and multiple layers of quality control ensures high-quality data that
can be leveraged for actionable research insights.
 Browse the report : Biosimilars Market
Research Methodology

5. Market Segmentation
 Biosimilars Market, by Product Types
 Recombinant Non-Glycosylated Proteins
 Recombinant Glycosylated Proteins
 Recombinant Peptides
 Biosimilars Market, by Applications
 Oncology
 Blood Disorders
 Infectious Diseases
 Autoimmune Diseases
 Others

6. Key Market Players
 Novartis International AG
 Stud Arzneimittel AG
 Amgen Inc.
 Pfizer Inc.
 Astra Zeneca plc
 Teva Pharmaceuticals Industries Ltd.
 Biocon Ltd.

7. Find out more about our services at : www.scalarmarketresearch.com
 Contact :
Mr. Rahul Ganju
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel. : +1-800-213-5170 (U.S./Canada Toll-free)
Email : sales@scalarmarketresearch.com
Follow us on LinkedIn : https://www.linkedin.com/company/scalar-market-research
Contact Info

8. Other Reports :
1. Stem Cell Therapy Market
2. In Vitro Diagnostics Market
3. Synthetic Biology Market
Thank You